Picture Kentro Design Corporate and Web Design Berlin 600x60px

News > All

Total search results: 16833 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 167 168 169

order ascendingorder descendingSource order ascendingorder descendingDate
TÜV Süd AG. (4/30/09). "Press Release: Auf dem Weg zu Nanoprodukten mit zertifizierter Sicherheit". München & Frankfurt a. M.. 2009-04-30
MeVis Medical Solutions AG. (4/30/09). "Press Release: MeVis Medical Solutions Confirms Preliminary Figures for Fiscal 2008. MeVis Group Remains on Growth Track in Spite of Difficult Market Conditions". Bremen. 2009-04-30
Rosetta Genomics Ltd.. (4/30/09). "Press Release: Rosetta Genomics Announces Closing of License and Collaboration Agreement". Rehovot. 2009-04-30
AstraZeneca plc. (4/30/09). "Press Release: AstraZeneca PLC First Quarter Results 2009". 2009-04-30
Roche. (4/29/09). "Press Release: Roche Steps Up Preparedness Level in Response to WHO’s Increase to Pandemic Alert Phase 4". Basel. 2009-04-29
InforSense Ltd.. (4/29/09). "Press Release: InforSense and Tessella Forge Strategic Partnership. InforSense and Tessella Partner to Deliver Scientific Intelligence for Improved Drug Discovery, Disease Understanding and Productivity". London, Cambridge, M 2009-04-29
Medigene AG. (4/29/09). "Press Release: Medigene AG Appoints Dr. Frank Mathias as New Chief Executive Officer". Martinsried. 2009-04-29
Qiagen N.V.. (4/28/2009). "Press Release: Qiagen Provides Solutions for Swine Flu Surveillance". Venlo. 2009-04-28
Epigenomics AG. (4/28/09). "Press Release: Epigenomics AG Licenses Biomarker for Development of Prostate Cancer Test to Predictive Biosciences". Berlin & Seattle, WA. 2009-04-28
Life Science Nord (Norgenta). (4/28/09). "Press Release: Hamburg, Schleswig-Holstein, Oberösterreich und Steiermark wachsen in den Lebenswissenschaften zusammen". Linz. 2009-04-28
Life Science Nord (Norgenta). (4/28/09). "Press Release: IMBA – Institut für Molekulare Biotechnologie und European ScreeningPort kooperieren auf dem Gebiet der modernen Medikamentenforschung". Wien. 2009-04-28
Sigma-Aldrich Corporation. (4/28/09). "Press Release: Sigma-Aldrich Introduces MISSION esiRNA for Low Cost, High Specificity Pooled RNAi Screening". St. Louis. 2009-04-28
General Electric Company. (4/28/09). "Press Release: GE Healthcare and Imricor Medical Systems Collaborate on Revolutionary MRI-guided Cardiac Electrophysiology System". Waukesha, WI. 2009-04-28
Omnilab-Laborzentrum GmbH & Co. KG. (4/27/09). "Press Release: OMNILAB neues Mitglied im Unternehmensverband Life Sciences Bremen (Pressemitteilung Nr. 03 / 2009)". Bremen. 2009-04-27
Protaffin Biotechnologie AG. (4/27/09). "Press Release: Protaffin AG Completes €14 Million Series B Financing Round". Graz. 2009-04-27
Roche. (4/27/09). "Press Release: Ground-breaking Combination of All-oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen. Combination of R7227, Protease Inhibitor, and R7128, Nucleoside Polymerase Inhibitor, Shows Signicant Potency". Base 2009-04-27
InforSense Ltd.. (4/27/09). "Press Release: InforSense Used by Celera to Further Investigate Genetic Markers for Coronary Heart Disease. InforSense Accelerates and Automates Diagnostic Biomarker Discovery". London & Cambridge, MA. 2009-04-27
Evotec AG. (4/27/09). "Press Release: Walter Wenninger Nominated for Election as New Supervisory Board Member of Evotec". Hamburg. 2009-04-27
Bruker Corporation. (4/27/09). "Press Release: Bruker Daltonics Launches the Fastest and most Flexible MALDI-TOF/TOF Mass Spectrometer with Unsurpassed Performance in Proteomics. Bruker’s Novel ultrafleXtreme with 1 kHz smartbeam-II Laser Technology Rede 2009-04-27
Antisense Pharma GmbH. (4/27/09). "Press Release: Antisense Pharma Begins Pivotal Phase III Clinical Trial with Trabedersen in Aggressive Brain Tumors. First Patients Enrolled in International SAPPHIRE Study of Recurrent or Refractory Anaplastic Astracyt 2009-04-27
Roche / Pharmasset, Inc.. (4/25/09). "Press Release: Roche and Pharmasset Initiate Phase IIb Clinical Trial of R7128, Most Advanced Nucleoside Polymersae Inhibitor in Development for Chronic Hepatitis C". Basel, Switzerland & Princeton, NJ. 2009-04-25
Pfizer Inc.. (4/24/09). "Press Release: Pfizer and University College London Announce Collaboration to Advance Development of Stem Cell-based Therapies. Goal of Collaboration between Pfizer Regenerative Medicine und UCL is the Development of Treatment fo 2009-04-24
Ascenion GmbH. (4/23/09). "Press Release: Removab Approval. Proof-of-Concept for Technology Transfer in Germany". Munich. 2009-04-23
bioMérieux S.A.. (4/23/09). "Press Release: First-Quarter 2009 Business Review. Sales Growth in Line with Objectives". Marcy l’Étoile. 2009-04-23
Trion Pharma GmbH. (4/23/09). "Press Release: EU Approval for Removab®: First Trifunctional Antibody Hits Market". Munich. 2009-04-23
Roche. (4/23/09). "Press Release: 454 Life Sciences Announces Comprehensive Solution for De Novo Sequencing and Assembly of Increasingly Complex Genomes". Branford, CT. 2009-04-23
Stratec Biomedical Systems AG. (4/23/09). "Press Release: Stratec Acquires Invitek". Birkenfeld. 2009-04-23
Universität Leipzig. (4/23/09). "Pressemitteilung: Sepsisbehandlung auf dem Prüfstand". 2009-04-23
InforSense Ltd.. (4/22/09). "Press Release: University of Greifswald Accelerates Genotyping Analysis with InforSense GenSense. GenSense Analyses Genotypic Data from 4100 Subjects in Study of Health in Pomerania Project". London & Cambridge, MA. 2009-04-22
Roche. (4/22/09). "Press Release: Phase III C-08 Study of Avastin in Early-Stage Colon Cancer Does Not Meet Primary Endpoint – Roche and Genentech Remain Committed to Avastin Adjuvant Programs". Basel. 2009-04-22
Santhera Pharmaceuticals Holding AG. (4/22/09). "Press Release: Santhera Enrolls Last Patient in Phase IIb FJORD Study with JP-1730/Fipamezole in Dyskinesia in Parkinson’s Disease". 2009-04-22
BIG Bremen. (4/22/09). "Pressemitteilung: Effektive Wirtschaftsförderung mit knappen Mitteln. Unternehmen investieren 300 Mio. Euro im Land Bremen – 4700 Arbeitsplätze gesichert und 1600 neu geschaffen". 2009-04-22
Poxel S.A.S.. (4/22/09). "Press Release: Poxel SAS Set-up to Find Innovative Solutions for Metabolic Diseases Management". 2009-04-22
next pagenext page 1 2 3 ... 167 168 169


Picture [LSUS] – The Business Web Portal 600x60px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 600x94px

» top